HS Dosing COSENTYX® (secukinumab)

Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition - Robert Bissonnette, Marc Bourcier, Melinda Gooderham, Chih-ho Hong, Ian Landells, Charles Lynde, Kim Papp, Yves Poulin, Ronald Vender

Cosentyx (Secukinumab)

These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX® (secukinumab) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2015

Cosentyx 150 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc)

Full article: Biologic Treatments of Psoriasis: An Update for the Clinician

Rheumatology Dosing, COSENTYX® (secukinumab)

Pediatric PsO Treatment Information, COSENTYX® (secukinumab)

Cosentyx SensoReady® Pen

Cosentyx 150mg/1.5mL Prefilled Syringe Injection, 150 mg/ml at Rs 1700/box in Nalagarh

Which treatment is safer for psoriasis between Humira (adalimumab) and Cosentyx (secukinumab) in the short and long term? - Quora